In-depth biotech analysis articles

In Depth 24 Jul 2023

Sarcoma research: is a breakthrough in sight?

Among the rarest forms of cancers, sarcomas develop in the bones and connective tissues that support structures in the body like blood vessels, nerves and joints. This year, around 13,400…

July 24, 2023 - 7 minutesmins - By Roohi Mariam Peter

In Depth 21 Jul 2023

How AI is shaping clinical research and trials

Artificial intelligence (AI) is everywhere at the minute, seemingly being used in some capacity in almost every professional industry, including clinical research and trials. In fact, it is fair to…

July 21, 2023 - 7 minutesmins - By Willow Shah-Neville

In Depth 19 Jul 2023

Genetic engineering giants: is China poised to lead the way?

For many people, when they hear China and genetic engineering in the same sentence, it is often synonymous with scandal, and gene-edited babies may spring to mind. And, although it…

July 19, 2023 - 7 minutesmins - By Willow Shah-Neville

Ziwig revolutionizes endometriosis diagnosis

In Depth 18 Jul 2023

Ten years to ten days: French startup revolutionizes early diagnosis of endometriosis with a saliva test

A condition that affects around 190 million women and girls worldwide, according to the World Health Organization, endometriosis is a chronic, difficult-to-treat disease that causes debilitating pelvic pain. Often misdiagnosed…

July 18, 2023 - 9 minutesmins - By Roohi Mariam Peter

In Depth 13 Jul 2023

Gold rush over: what happens to biotech now that venture capital is out of reach?

If you were to look back just a little over two years ago to the start of 2021, then putting money into a biotech company seemed like a pretty safe…

July 13, 2023 - 7 minutesmins - By Willow Shah-Neville

In Depth 12 Jul 2023

Medicon Valley: how the initiative shaped biotech ecosystems in Denmark and Sweden

With a combined market value of over $7 billion, the life science sectors in Sweden and Denmark are thriving, with over a thousand healthcare companies being set up over the…

July 12, 2023 - 10 minutesmins - By Roohi Mariam Peter

In Depth 11 Jul 2023

AIS Biotech: startup employs carbohydrates to fight the flu

Keen on discovering novel ways to tackle viral infections, AIS Biotech, a French company based in the Alps, aims to combat influenza, more commonly known as the flu, by leveraging…

July 11, 2023 - 6 minutesmins - By Roohi Mariam Peter

In Depth 10 Jul 2023

“Ready-to-use” enzymatically produced cell-free synthetic DNA in mRNA manufacturing

By Ashish Dhir, PhD and Amy Walker, PhD, 4basebio The pace, efficacy and scalability with which the success of mRNA vaccines against COVID-19 was demonstrated opened endless possibilities for mRNA…

July 10, 2023 - 6 minutesmins - By External Contributor

In Depth 10 Jul 2023

Making an impact through targeting mRNA

Biotech company Molecure develops small molecule therapies that can regulate RNA and underexplored protein targets for the treatment of incurable diseases, including cancer and fibrotic and inflammatory diseases. The company,…

July 10, 2023 - 7 minutesmins - By Jim Cornall

In Depth 10 Jul 2023

Unleashing the potential: Optimizing mRNA for the discovery of transformative medicines

By Dr. Alexander Zehnder, CEO, CureVac The success of mRNA vaccines in COVID-19 propelled the role of this new modality to the forefront of medicine. Not only are new prophylactic…

July 10, 2023 - 8 minutesmins - By External Contributor

In Depth 7 Jul 2023

The future of food: what’s behind the cell-cultured meat industry regulations?

The first-ever lab-grown burger was created at Maastricht University in the Netherlands, and eaten at a news conference in London in 2013. While everyone who tried a bite had something…

July 7, 2023 - 8 minutesmins - By Roohi Mariam Peter

In Depth 6 Jul 2023

The biggest private biotech investments in June 2023

The companies Upstream Bio, Alkeus Pharmaceuticals and Worg Pharmaceuticals bagged the biggest biotech investments in June 2023, with oncology and ophthalmology players in particular attracting the most funding rounds. Overall,…

July 6, 2023 - 2 minutesmins - By Willow Shah-Neville

In Depth 3 Jul 2023

Hepatitis B: are we edging closer to a cure?

A viral infection that affects the liver and can cause both acute and chronic disease, hepatitis B affects around 296 million people worldwide, and, according to the latest statistics from…

July 3, 2023 - 6 minutesmins - By Willow Shah-Neville

In Depth 27 Jun 2023

The promise of immunotherapy for autoimmune diseases

Our immune system serves as the body’s chief line of defense against harmful invaders. But what happens when this mighty defense mechanism turns on its own host, launching an assault…

June 27, 2023 - 9 minutesmins - By Roohi Mariam Peter

In Depth 22 Jun 2023

Brace yourself for a wave of biotech layoffs

In the ever-evolving field of biotechnology spearheaded by discoveries that fuel therapeutic success, of late, the industry is taking measures to optimize the workforce amid economic uncertainty. Or to put…

June 22, 2023 - 6 minutesmins - By Roohi Mariam Peter

In Depth 19 Jun 2023

Gene therapy: a promising solution for sickle cell disease

Sickle cell disease is debilitating, and many people who suffer with it find that their lives are defined by pain. This means a curative treatment would be completely life–altering, and,…

June 19, 2023 - 6 minutesmins - By Willow Shah-Neville

In Depth 16 Jun 2023

Can ChatGPT be used to advance drug discovery?

Chat GPT - which is a large language model (LLM) and belongs to a family of artificial intelligence (AI) known as generative AI - has been a revelation for many…

June 16, 2023 - 6 minutesmins - By Willow Shah-Neville

In Depth 14 Jun 2023

How are biotechs addressing rare chromosome disorders?

Human beings typically have 23 pairs of chromosomes. But sometimes, in rare cases, an error during cell division can result in cells having extra or missing chromosomes, indicative of chromosomal…

June 14, 2023 - 7 minutesmins - By Roohi Mariam Peter

In Depth 13 Jun 2023

Abeta-targeting antibodies pave the way for Alzheimer’s disease vaccines

By Dr. Andrea Pfeifer, CEO of AC Immune SA The clinical success we’ve recently seen with two monoclonal antibodies that target the protein amyloid beta (Abeta) has provided hope for…

June 13, 2023 - 7 minutesmins - By External Contributor

In Depth 9 Jun 2023

Enhancing canine wellness: The promise of immunotherapy for dogs

Given that dogs are widely regarded as ‘man’s best friend’, it makes sense that we are constantly striving to find ways to improve canine health. One method that has been…

June 9, 2023 - 8 minutesmins - By Willow Shah-Neville

Report: new Frontiers in Vaccinology

Listen to our podcast

View all sectors A-Z

Power your event with partnering to deliver attendee ROI. Learn more!

View all companies A-Z

Find new scientific partnerships. Create a free IN-PART account

View all countries A-Z

Report: The European Biotech Startup Ecosystem

Subcribe to our newsletter

Learn more about Inova, the leading platform for biopharma partnering

Report: new Frontiers in Vaccinology

Listen to our podcast

View all sectors A-Z

Power your event with partnering to deliver attendee ROI. Learn more!

View all companies A-Z

Find new scientific partnerships. Create a free IN-PART account

View all countries A-Z

Report: The European Biotech Startup Ecosystem

Subcribe to our newsletter

Learn more about Inova, the leading platform for biopharma partnering

Outsourcing in life science R&D today

Power your event with partnering to deliver attendee ROI.

Looking to expand your network?

Subscribe to our newsletter to get the latest biotech news!